Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 173–173 | Cite as

Dolutegravir/elvitegravir/raltegravir

Congenital malformations following in-utero exposure: 6 case reports
Case report
  • 9 Downloads

Reference

  1. Chouchana L, et al. Is There a Safety Signal for Dolutegravir and Integrase Inhibitors during Pregnancy? JAIDS 81: 481-486, No. 4, 01 Aug 2019. Available from: URL: http://doi.org/10.1097/QAI.0000000000002065 - France

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations